Aurora Cannabis (ACB) Competitors C$5.91 +0.03 (+0.51%) As of 04/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ACB vs. THCX, CRON, GUD, TLRY, FIRE, EPI, ICC, RIV, WEED, and CPHShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), RIV Capital (RIV), Canopy Growth (WEED), and Cipher Pharmaceuticals (CPH). These companies are all part of the "drug manufacturers - specialty & generic" industry. Aurora Cannabis vs. Hydropothecary Cronos Group Knight Therapeutics Tilray Brands Supreme Cannabis ESSA Pharma ICC Labs RIV Capital Canopy Growth Cipher Pharmaceuticals Aurora Cannabis (TSE:ACB) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation, community ranking and profitability. Is ACB or THCX more profitable? Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-22.55% -8.36% -1.87% Hydropothecary N/A N/A N/A Do analysts prefer ACB or THCX? Aurora Cannabis currently has a consensus price target of C$8.75, suggesting a potential upside of 48.05%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, research analysts plainly believe Aurora Cannabis is more favorable than Hydropothecary.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 3.33Hydropothecary 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor ACB or THCX? In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score. Company Overall Sentiment Aurora Cannabis Neutral Hydropothecary Neutral Do insiders & institutionals believe in ACB or THCX? 13.4% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in ACB or THCX? Aurora Cannabis received 390 more outperform votes than Hydropothecary when rated by MarketBeat users. However, 72.31% of users gave Hydropothecary an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes53163.14% Underperform Votes31036.86% HydropothecaryOutperform Votes14172.31% Underperform Votes5427.69% Which has preferable earnings and valuation, ACB or THCX? Hydropothecary has lower revenue, but higher earnings than Aurora Cannabis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora CannabisC$195.83M1.65-C$44.16M-C$0.81-7.30HydropothecaryN/AN/AN/AN/AN/A SummaryAurora Cannabis beats Hydropothecary on 6 of the 10 factors compared between the two stocks. Remove Ads Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$323.33MC$2.15BC$5.33BC$5.47BDividend YieldN/A2.92%5.11%6.84%P/E Ratio-7.304.2821.6631.24Price / Sales1.65450.55373.39544.75Price / Cash1.2510.2538.1582.93Price / Book0.546.256.473.54Net Income-C$44.16MC$20.70BC$3.20BC$299.64M7 Day Performance-1.34%1.81%2.86%2.06%1 Month Performance-6.78%-2.33%-8.56%-2.79%1 Year Performance-27.66%96.07%10.58%10.17% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis1.359 of 5 starsC$5.91+0.5%C$8.75+48.1%-31.5%C$323.33MC$195.83M-7.301,073THCXHydropothecaryN/AC$5.30+6.6%N/A+0.0%C$949.11MN/A0.00N/AHigh Trading VolumeCRONCronos Group1.1049 of 5 starsC$2.37-2.5%C$3.54+49.4%-28.7%C$625.83MC$76.86M-13.19450GUDKnight TherapeuticsN/AC$5.69-2.9%C$7.48+31.4%-0.3%C$575.54MC$348.70M-19.00725Gap DownHigh Trading VolumeTLRYTilray BrandsN/AC$0.81-3.6%N/A-72.9%C$521.94MC$610.34M-1.962,650FIRESupreme CannabisN/AN/AN/AN/AC$259.40MC$53.29M-10.97400EPIESSA PharmaN/AC$8.20+7.2%N/A+0.0%C$237.87MN/A-8.2725ICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/ANews CoverageGap UpRIVRIV CapitalN/AN/AN/AN/AC$213.65MC$11.33M-1.6312WEEDCanopy Growth1.4459 of 5 starsC$1.32+1.5%C$5.64+327.1%-85.3%C$212.35MC$519.68M-0.192,700CPHCipher Pharmaceuticals1.1311 of 5 starsC$11.63-4.8%C$14.75+26.8%+30.7%C$208.80MC$19.03M12.845High Trading Volume Remove Ads Related Companies and Tools Related Companies THCX Alternatives CRON Alternatives GUD Alternatives TLRY Alternatives FIRE Alternatives EPI Alternatives ICC Alternatives RIV Alternatives WEED Alternatives CPH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:ACB) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
